Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.9179 USD | +2.10% | +13.87% | +13.32% |
Apr. 25 | Transcript : HOOKIPA Pharma Inc. - Special Call | |
Apr. 25 | HOOKIPA Pharma Inc. Announces Pivotal Phase 2/3 Trial Design for HB-200 in Combination with Pembrolizumab | CI |